Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Net cash flow from investing | -$15.50M | $20.20M | -$38.60M | -$26.20M | -$32.80M |
| -Change In Other Working Capital | -$67.90M | -$7.60M | $81.30M | -$54.50M | -$42.60M |
| -Change in Payables and Accrued Expense | $22.70M | $30.30M | $20.10M | $32.90M | -$37.70M |
| -Change in Inventory | -$44.10M | -$38.70M | $78.30M | -$18.20M | $9.80M |
| -Change in Receivables | $23.00M | $3.80M | -$28.10M | $20.60M | $33.00M |
| Change in Working Capital | -$66.30M | -$12.20M | $151.60M | -$19.20M | -$37.50M |
| Other Non-Cash Items | $1.70M | $3.10M | $2.00M | $1.90M | $3.10M |
| Deferred Tax | $900,000.00 | $1.30M | -$16.60M | -$22.70M | -$6.80M |
| Depreciation & Depletion & Amortization | $30.80M | $31.40M | $30.70M | $31.70M | $31.20M |
| Gain/Loss from Continuing Operations | -$1.10M | -$600,000.00 | -$3.50M | $1.00M | $24.00M |
| Net Income from Continuing Operations | $16.20M | $5.50M | $50.50M | $41.70M | $12.80M |
| Net cash flow from continuing operations | -$13.60M | $31.70M | $217.50M | $37.40M | $30.10M |
| Net Cash Flow from Continuing Investing Activities | -$15.50M | $20.20M | -$38.60M | -$26.20M | -$32.80M |
| Capital Expenditure | -$15.30M | -$11.00M | -$21.80M | -$12.90M | -$17.40M |
| Net Investment Purchase and Sale | -$300,000.00 | $29.10M | -$12.40M | $7.60M | -$17.20M |
| Free Cash Flow | -$28.90M | $20.70M | $195.70M | $24.50M | $12.70M |
| Effect of Exchange Rate Changes | $400,000.00 | -$3.40M | $1.50M | $300,000.00 | $9.00M |
| Beginning Cash Balance | $373.60M | $387.30M | $262.60M | $295.20M | $320.20M |
| Net Change in Cash | -$91.60M | -$10.30M | $123.20M | -$32.90M | -$34.00M |
| Ending Cash Balance | $282.40M | $373.60M | $387.30M | $262.60M | $295.20M |
| Net Other Financing Charges | -$1.90M | -$1.80M | -$4.60M | -$4.20M | -$1.20M |
| Net Common Stock Issuance | -$60.60M | -$60.40M | -$51.10M | -$39.90M | -$30.10M |
| Net Cash Flow from Continuing Financing Activities | -$62.50M | -$62.20M | -$55.70M | -$44.10M | -$31.30M |
| Financing Cash Flow | -$62.50M | -$62.20M | -$55.70M | -$44.10M | -$31.30M |
| Net Other Investing Changes | $100,000.00 | $2.10M | $1.70M | -$2.50M | – |
| Operating Cash Flow | -$13.60M | $31.70M | $217.50M | $37.40M | $30.10M |
| Net Business Purchase and Sale | – | – | -$6.10M | – | – |
| Net Issuance Payments Of Debt | – | – | $0.00 | – | – |
No comments yet — be the first to weigh in on DBD.